Amicus Therapeutics Inc. buy Morgan Stanley
Start price
11.10.24
/
50%
€9.45
Target price
11.10.25
€16.44
Performance (%)
-24.34%
End price
12.10.25
€7.15
Summary
This prediction ended on 12.10.25 with a price of €7.15. The prediction for Amicus Therapeutics Inc. disappointed with a performance of -24.34%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amicus Therapeutics Inc. | 8.982% | 8.982% | -2.674% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Morgan_Stanley for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at Morgan Stanley from $19.00 to $18.00. They now have an "overweight" rating on the stock.
Ratings data for FOLD provided by MarketBeat
In the thread Trading Amicus Therapeutics Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Morgan_Stanley for Amicus Therapeutics Inc.
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.60
10.05.24
10.05.24
€17.64
10.05.25
10.05.25
-37.79%
11.05.25
11.05.25
Amicus Therapeutics Inc.
Start price
Target price
Perf. (%)
€12.00
19.12.23
19.12.23
€18.24
19.12.24
19.12.24
-22.50%
20.12.24
20.12.24